Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coronavirus
Reports by B.K. Bai and co-researchers describe recent advances in coronavirus
April 9th, 2008
"Continuous efforts have been made to develop a prophylactic vaccine against severe acute respiratory syndrome coronavirus (SARS-CoV). In this study, two recombinant baculoviruses, vAc-N and vAc-S, were constructed, which contained the mammalian-cell activate promoter element, human elongation factor la-subunit (EF-1 alpha), the human cytomegalovirus (CMV) immediate-early promoter, and the nucleocapsid (N) or spike (S) gene of bat SARS-like CoV (SL-CoV) under the control of the CMV promoter," scientists in Wuhan, People's Republic of China report. "Mice were subcutaneously and intraperitoneally injected with recombinant baculovirus, and both humoral and cellular immune...
Source: Vaccine Weekly (2008-04-09)
|
